Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 April 2018 to Question 135010 on Sickle Cell Diseases, if he will provide updated estimates of the costs to the NHS of treating sickle cell anaemia in (a) England (b) each NHS England region and (c) each Clinical Commissioning Group area in each year since 2009-10.
NHS England specialised commissioning only reports the costs of the National Health Service specialised commissioning services by region and hub for treating sickle cell disease, which includes sickle cell anaemia. This information is shown in the following table. The data is not broken down by clinical commissioning group (CCG) area. This information does not include non-specialised activity that CCGs may fund. Information was not collected prior to 2015/16 and information for 2018/19 is not currently available.
Costs of NHS specialised commissioning services by region and hub for treating sickle cell disease
Region | Hub | 2015/16 | 2016/17 | 2017/18 |
|
| £ million | £ million | £ million |
London |
| 29.9 | 31.0 | 44.8 |
|
|
|
|
|
Midlands and East | East of England | 1.6 | 1.7 | 3.3 |
| East Midlands | 0.8 | 0.8 | 1.4 |
| West Midlands | 2.7 | 2.5 | 3.2 |
Midlands and East Total |
| 5.1 | 5.0 | 7.9 |
|
|
|
|
|
North | North East | 0.1 | 0.2 | 0.2 |
| North West | 2.8 | 2.3 | 2.3 |
| Yorkshire & Humber | 1.1 | 0.5 | 0.9 |
North Total |
| 4.0 | 3.0 | 3.4 |
|
|
|
|
|
South | South East | 1.8 | 1.9 | 2.6 |
| South West | 0.2 | 0.2 | 0.7 |
| Wessex | 0.5 | 0.5 | 0.9 |
South Total |
| 2.5 | 2.5 | 4.2 |
|
|
|
|
|
|
| 41.6 | 41.5 | 60.4 |
Source: Costs extracted from the annual CCG exercise.
Between 2012/13 and 2018/19, approximately 117,000 patients were admitted to hospital with a primary diagnosis of sickle cell disease. Information for years prior to 2012/13 is not available. NHS England has advised that it is unable to separate expenditure between admitted patient care episodes and the overall costs provided in the table without incurring disproportionate cost.